HEIDELBERG PHARMA AG (HPHA.DE) Forecast, Price Target & Analyst Ratings

FRA:HPHA • DE000A11QVV0

Current stock price

2.84 EUR
+0.06 (+2.16%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEIDELBERG PHARMA AG (HPHA.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€5.61
+ 97.54% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jul 15, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€5.61
Upside
+ 97.54%
From current price of €2.84 to mean target of €5.61, Based on 8 analyst forecasts
Low
€5.56
Median
€5.61
High
€5.78

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for HPHA.DE. The average price target is 5.61 EUR. This implies a price increase of 97.54% is expected in the next year compared to the current price of 2.84.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

HPHA Current Analyst RatingHPHA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

HPHA Historical Analyst RatingsHPHA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
HPHA.DE was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HPHA.DE.
In the previous month the buy percentage consensus was at a similar level.
HPHA.DE was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jul 15, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027
Revenue
YoY % growth
HPHA.DE revenue by date.HPHA.DE revenue by date.
9.859M
-46.75%		6.849M
-30.53%		1.457M
-78.72%		10.2M
599.88%		13.26M
30.00%
EBITDA
YoY % growth
HPHA.DE ebitda by date.HPHA.DE ebitda by date.
-20.423M
-16.69%		-22.98M
-12.52%		-43.015M
-87.18%		-13.311M
69.06%		-8.262M
37.93%
EBIT
YoY % growth
HPHA.DE ebit by date.HPHA.DE ebit by date.
-21.302M
-16.66%		-23.852M
-11.97%		-45.833M
-92.16%		-13.821M
69.85%		-9.894M
28.41%
Operating Margin
HPHA.DE operating margin by date.HPHA.DE operating margin by date.
-216.07%-348.23%-3,144.87%-135.50%-74.62%
EPS
YoY % growth
HPHA.DE eps by date.HPHA.DE eps by date.
N/A
-12.50%		N/A
40.28%		N/A
-44.19%		-0.30
53.23%		-0.20
31.03%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HPHA.DE Yearly Revenue VS EstimatesHPHA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
HPHA.DE Yearly EPS VS EstimatesHPHA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HEIDELBERG PHARMA AG / HPHA.DE Forecast FAQ

What do analysts expect the price target to be for HEIDELBERG PHARMA AG (HPHA.DE)?

8 analysts have analysed HPHA.DE and the average price target is 5.61 EUR. This implies a price increase of 97.54% is expected in the next year compared to the current price of 2.84.

When does HEIDELBERG PHARMA AG (HPHA.DE) report earnings?

HEIDELBERG PHARMA AG (HPHA.DE) will report earnings on 2026-07-15.

What is the number of analysts for HPHA stock?

The number of analysts covering HEIDELBERG PHARMA AG (HPHA.DE) is 8.